Table 4. Hazard ratios for allograft failure with adjustment for competing risks in 2,902 subjects.

		Without competing risk		With competing risk of cardiac death		With competing risks of cardiac & unknown death
		HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p
Model 1*
Pre-transplant CV Risk Score§	1st tertile	1.00		1.00		1.00
	2nd tertile	1.19 (0.89–1.60)	0.237	1.16 (0.84–1.59)	0.370	1.17 (0.86–1.61)	0.320
	3rd tertile	1.65 (1.22–2.23)	0.001	1.54 (1.10–2.15)	0.012	1.46 (1.05–2.03)	0.025
Model 2*
Pre-transplant CV Risk Score (per 1 score increase)		1.05 (1.02–1.07)	0.001	1.04 (1.01–1.07)	0.026	1.03 (1.01–1.06)	0.029
Model 3*
Vascular disease		2.51 (1.66–3.80)	<0.001	2.05 (1.25–3.38)	0.005	2.19 (1.35–3.55)	0.002

* In models 1–3, adjustments for recipient gender, induction therapy, donor age, donor type, recurrent glomerulonephritis, and biopsy-proven acute rejection were performed.

^§ 1^st tertile, 0–4 in men and 0–4 in women; 2^nd tertile, 5–10 in men and 5–8 in women; 3^rd tertile, ≥ 11 in men and ≥ 9 in women